NDC 68071-3994-04 - Scopolamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68071-3994
- Requested NDC
- 68071-3994-04
- Package NDCs from labels
- 68071-3994-4, 68071-3994-04
- Manufacturer
- NuCare Pharmaceuticals, Inc.
- Effective date
- 2026-05-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Scopolamine - NuCare Pharmaceuticals, Inc. | NuCare Pharmaceuticals, Inc. | 2026-05-06 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-3994-4 | Scopolamine | 1 in 1 POUCH | PATCH, EXTENDED RELEASE | 1 | 1 | |
| 68071-3994-4 | Scopolamine | 4 in 1 CARTON | PATCH, EXTENDED RELEASE | 4 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Scopolamine | SCOPOLAMINE | Ingenus Pharmaceuticals, LLC | 2a6f9aaf-a70a-481f-a82b-1dcaaadc185b | 2026-09-09 | Warnings, Adverse reactions | ANDA212342 50742-505 226552 3baa2417-8daa-4253-89a4-fef4be344fc1 2a6f9aaf-a70a-481f-a82b-1dcaaadc185b DL48G20X8X |
| Tox-Chord | ALFALFA, ALUMINA, BENZOICUM AC, CARBONEUM, CETRARIA, FOLLICULINUM, FUCUS, FUMARICUM AC, HEPAR SUIS, KALI CARB, KREOSOTUM, NAT MUR, PARAFFINUM, PETROLEUM, PHOSPHORICUM AC, PHOS, PIX LIQUIDA, PLANTAGO, PLUMB MET, PULSATILLA, RADIUM BROM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM, TABACUM, TEREBINTHINA, THYROIDINUM, TRITICUM, ZINC OXYD. | Energetix Corporation | b06b4794-e5bb-4ccd-87fd-37afca7b0f98 | 2026-08-11 | Warnings | 4XYU5U00C4 |
| Scopolamine | SCOPOLAMINE | Rhodes Pharmaceuticals LLC | ba5a1237-4d23-441a-808e-96b97045fbe2 | 2026-05-06 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | NuCare Pharmaceuticals, Inc. | 51289d8b-f7e3-a3e0-e063-6294a90add43 | 2026-05-06 | Warnings, Adverse reactions | ANDA212342 68071-3994-4 68071-3994 68071399404 226552 51288b87-a0ea-5505-e063-6394a90a3736 51289d8b-f7e3-a3e0-e063-6294a90add43 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | Bryant Ranch Prepack | 5aa64f85-ae52-4a86-a894-a4e536fbe4ad | 2026-04-16 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | Bryant Ranch Prepack | dd031a59-6b8c-49b1-9b4d-e7a7b75e3801 | 2026-04-16 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | Bryant Ranch Prepack | 8d53ee59-e0ef-4332-a6d6-0ac5a6c21b55 | 2026-04-16 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | Bryant Ranch Prepack | a472ee74-76a7-470f-8564-9018940a82e8 | 2026-03-16 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | Zydus Pharmaceuticals USA Inc. | 62d8332e-b8d2-4d13-8071-978d57e51928 | 2025-08-23 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | Zydus Lifesciences Limited | 016df9f3-61d5-45e9-b1d6-791a5d2f26d5 | 2025-08-23 | 226552 DL48G20X8X | |
| Scopolamine Transdermal System | SCOPOLAMINE TRANSDERMAL SYSTEM | Bryant Ranch Prepack | 8455ce88-1270-440b-b62e-fe5fef1415ac | 2025-07-31 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | Mylan Pharmaceuticals Inc. | 163accb7-45e6-4d97-844d-72b606677008 | 2025-07-08 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| scopolamine | SCOPOLAMINE | Actavis Pharma, Inc. | 800b6421-48eb-47f5-b255-c12f75e59068 | 2025-06-12 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Transderm Scop | SCOPOLAMINE | Baxter Healthcare Corporation | b877a694-a1d0-4280-937a-a06820b12a88 | 2025-06-10 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine Transdermal System | SCOPOLAMINE TRANSDERMAL SYSTEM | Padagis Israel Pharmaceuticals Ltd | cb93bfad-3e37-4a27-92f6-f21703ae7bdf | 2025-05-31 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Scopolamine | SCOPOLAMINE | Amneal Pharmaceuticals NY LLC | 48e6e53a-d904-475b-84dd-6068cc0cb36b | 2025-05-01 | Warnings, Adverse reactions | 226552 DL48G20X8X |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PROPYLPARABEN, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR, PARAFFINUM | Energique, Inc. | f3db63df-62a4-48d6-92e7-94e4a5701552 | 2024-12-20 | Warnings | 76845O8NMZ |
| Household Detox | ALLIUM SATIVUM, ALUMINA, ANTIPYRINUM, BENZINUM, BISPHENOL A, CARBOLICUM ACIDUM, CARBONEUM SULPHURATUM, DIETHYLSTILBESTROL, DIOXIN, FOLLICULINUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PARAFFINUM, PETROLEUM, PHENACETINUM, PTELEA TRIFOLIATA, SODIUM CARBOXYMETHYL CELLULOSE, TEFLON | Deseret Biologicals, Inc. | 7f79058a-c35a-429a-be3c-4cff1d657087 | 2024-12-13 | Warnings | E1NC1JVS3O |
| Household Detox | PTELEA TRIFOLIATA, ALLIUM SATIVUM, PETROLEUM, CARBONEUM SULPHURATUM, ALUMINA, BENZINUM, BISPHENOL A, CARBOLICUM ACIDUM, FORMALINUM, GLYPHOSATE, METHYLPARABEN, NAPHTHALINUM, PARAFFINUM, PHENACETINUM, SODIUM CARBOXYMETHYL CELLULOSE, FOLLICULINUM, ANTIPYRINUM, DIOXIN, DIETHYLSTILBESTROL, TEFLON | Deseret Biologicals, Inc. | 7e32c1f4-c88e-43d0-9f6c-de736d358d46 | 2024-09-27 | Warnings | E1NC1JVS3O |
| Household Antigens | ACETONE, SODIUM TRIPOLYPHOSPHATE, PROPYLENE GLYCOL, BENZINUM, AMMONIUM MURIATICUM, SODIUM LAURYL SULFATE, TEREBINTHINA, BUTYL ACETATE, ETHYL ACETATE, TOLUENE, XYLENE, BISPHENOL A, PETROLEUM, ANACARDIUM ORIENTALE, GRAPHITES, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), SULPHUR | Energique, Inc. | 87c92497-8a51-4977-87fe-e0b4c6bafb19 | 2024-09-27 | Warnings | 76845O8NMZ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.